I prefer the old simple metrics - MC of $60m and EV of $40m ($16m+$4m tax rec).(F/C are just theoretical unless paid out IMO).To value DSK, it's about understanding normalised earnings.The past couple of years are irrelevant as they were clearly over-earning.On the other side because it listed during covid and most in the industry are males they've marked DSK down as a fad - they think gifting is dead and women don't want nice smelling items!But actually in pre-Covid FY19 (the last normalised time) they were doing $9m NPAT from 100 stores and continually growing YoY.They've now increased stores by 50%.With a little bit of operating leverage that's a ballpark normalised $15m NPAT at current store count.That gives current metrics of 4x P/E (with a third covered by cash).On a 70% payout ratio that's 17.5% divi yield or 25% grossed up.Incredible numbers.Then add store growth on top.
So apply whatever multiple you want to normalised earnings.I've said it before: Operating leverage + cyclicality + seasonality are a powerful cocktail.The question is when is normal again?FY24 will likely be tough. That will reinvigorate the bears further.The only thing that matters is that they survive - which they will given cash backing and available facilities in the unlikely event of a strong downturn.So it's more likely a FY25 play. It'll move before then as the market is forward looking. For now, best to switch off (nothing you can do).The market is good on a 6-12 month time horizon but poor beyond that - that's the opportunity.Throw in our new CEO and international expansion and that ups the multiple further.Speaking of which, Vlad started today....
- Forums
- ASX - By Stock
- DSK
- What's it worth ?
What's it worth ?, page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DSK (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.17 |
Change
0.030(2.63%) |
Mkt cap ! $72.85M |
Open | High | Low | Value | Volume |
$1.15 | $1.18 | $1.14 | $101.5K | 87.55K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8569 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 22000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8569 | 1.170 |
1 | 3000 | 1.165 |
1 | 5000 | 1.160 |
1 | 14000 | 1.140 |
1 | 381 | 1.135 |
Price($) | Vol. | No. |
---|---|---|
1.175 | 22286 | 2 |
1.180 | 21453 | 1 |
1.220 | 40000 | 1 |
1.230 | 5000 | 1 |
1.240 | 7896 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
DSK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online